Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases
The problem of comorbid infections in rheumatology seems to be very relevant in connection with the active introduction into clinical practice of innovative disease-modifying anti-rheumatic drugs (DMARDs), the so-called targeted DMARDs (tDMARDs), as well as genetically engineered biological drugs (b...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
Remedium Group LLC
2021-12-01
|
| Saila: | Медицинский совет |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.med-sovet.pro/jour/article/view/6547 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|